💨 Abstract

Prescription drug distributor Cencora, Inc. (COR) reported a fiscal second-quarter profit of $717.9 million, or $3.68 per share. Adjusted earnings were $4.42 per share, surpassing Wall Street's expectations of $4.08 per share. The company's revenue for the period was $75.45 billion, also beating forecasts of $74.82 billion.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖

Powered by MessengerX.io